Cite

    Hou, J. et al. (2022). Ginsenoside Rh2 mitigates doxorubicin‐induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer‐bearing mice. Cell proliferation. 55 (6), p. n/a. [Online].